Grufity logo
Grufity logo

Latest Artia Global Partners LP Stock Portfolio

$499Million | No. of Holdings #48

Artia Global Partners LP Performance

2026 Q1-6.18%
YTD-6.18%
2025+43.83%

About Artia Global Partners LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Artia Global Partners LP reported an equity portfolio of $499.4 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Artia Global Partners LP are INSM, , LLY. The fund has invested 29.7% of it's portfolio in INSMED INC and 13.4% of portfolio in ABIVAX SA. <br><br> The fund managers got completely rid off PROSHARES TR II (AGQ), UNIQURE NV (QURE) and ASTRAZENECA PLC (AZN) stocks. They significantly reduced their stock positions in SOLENO THERAPEUTICS INC (SLNO), VIKING THERAPEUTICS INC (VKTX) and ARGENX SE (ARGX). Artia Global Partners LP opened new stock positions in ASTRAZENECA PLC, MERCK & CO INC (MRK) and TERNS PHARMACEUTICALS INC (TERN). The fund showed a lot of confidence in some stocks as they added substantially to XENON PHARMACEUTICALS INC (XENE), BELITE BIO INC (BLTE) and BRIGHTSPRING HEALTH SVCS INC.
Artia Global Partners LP Equity Portfolio Value
Last Reported on: 15 May, 2026
$499Million
  as of May 15, 2026

Artia Global Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Artia Global Partners LP made a return of -6.18% in the last quarter. In trailing 12 months, it's portfolio return was 25.32%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
astrazeneca plc18,810,100
alumis inc7,160,760
merck & co inc5,617,540
terns pharmaceuticals inc5,525,060
johnson & johnson5,524,340
biogen inc3,380,060
edgewise therapeutics inc2,063,250
cytokinetics inc1,074,330
New stocks bought by Artia Global Partners LP

Additions

Ticker% Inc.
xenon pharmaceuticals inc62.5
belite bio inc38.91
brightspring health svcs inc29.33
celcuity inc20.74
revolution medicines inc19.96
bright minds biosciences inc14.97
Additions to existing portfolio by Artia Global Partners LP

Reductions

Ticker% Reduced
soleno therapeutics inc-87.17
viking therapeutics inc-74.88
argenx se-54.03
nuvalent inc-39.51
avalo therapeutics inc-30.31
eli lilly & co-24.32
dianthus therapeutics inc-20.53
insmed inc-17.58
Artia Global Partners LP reduced stake in above stock

Sold off

Ticker$ Sold
uniqure nv-24,493,300
ventyx biosciences inc-6,284,720
proshares tr ii-30,098,400
astrazeneca plc-17,535,800
ocular therapeutix inc-1,712,480
cidara therapeutics inc-15,644,300
upstream bio inc-1,863,930
avidity biosciences inc-4,335,010
Artia Global Partners LP got rid off the above stocks

Sector Distribution

Artia Global Partners LP has about 64% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare64
Others36

Market Cap. Distribution

Artia Global Partners LP has about 49.1% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • UNALLOCATED
  • MEGA-CAP
  • SMALL-CAP
  • MID-CAP
Category%
LARGE-CAP39
UNALLOCATED36
MEGA-CAP10.1
SMALL-CAP7.1
MID-CAP6.7

Stocks belong to which Index?

About 58% of the stocks held by Artia Global Partners LP either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
  • S&P 500
Index%
RUSSELL 200045.6
Others41.9
S&P 50012.4
Top 5 Winners (%)%
dianthus therapeutics inc
93.0 %
KOD
kodiak sciences inc
36.3 %
TENX
tenax therapeutics inc
31.2 %
ROIV
roivant sciences ltd
27.6 %
XENE
xenon pharmaceuticals inc
22.7 %
Top 5 Winners ($)$
dianthus therapeutics inc
7.9 M
RVMD
revolution medicines inc
2.0 M
DGX
quest diagnostics inc
0.9 M
ROIV
roivant sciences ltd
0.8 M
XENE
xenon pharmaceuticals inc
0.7 M
Top 5 Losers (%)%
PEPG
pepgen inc
-72.8 %
EYPT
eyepoint inc
-29.4 %
PALI
palisade bio inc
-25.5 %
mineralys therapeutics inc
-25.4 %
TVTX
travere therapeutics inc
-22.3 %
Top 5 Losers ($)$
abivax sa
-14.1 M
INSM
insmed inc
-10.6 M
LLY
eli lilly & co
-6.9 M
ARGX
argenx se
-5.2 M
EYPT
eyepoint inc
-4.1 M

Artia Global Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Artia Global Partners LP

Artia Global Partners LP has 48 stocks in it's portfolio. About 73.7% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Artia Global Partners LP last quarter.

$489.26MTotal Value
60.00Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of Artia Global Partners LP, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AGQ
Proshares Tr Ii

Proshares Tr Ii

AGQ
Artia Global Partners LP's holding in Proshares Tr Ii over time
0%0.00
$0.00
0%
decreased 100 percentsold off
ARGX
Argenx Se

Argenx Se

ARGX
Artia Global Partners LP's holding in Argenx Se over time
4.35%29,739
$21.72M
4.35%
decreased 54.03 percentreduced
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Artia Global Partners LP's holding in Ascendis Pharma A/S over time
0.81%17,740
$4.06M
0.81%
unchanged 0 percentunchanged
AZN
Astrazeneca Plc

Astrazeneca Plc

AZN
Artia Global Partners LP's holding in Astrazeneca Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off
BLTE
Belite Bio Inc

Belite Bio Inc

BLTE
Artia Global Partners LP's holding in Belite Bio Inc over time
0.8%24,989
$3.98M
0.8%
increased 38.91 percentadded
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Artia Global Partners LP's holding in Bright Minds Biosciences Inc over time
0.56%38,407
$2.80M
0.56%
increased 14.97 percentadded